发明名称 |
Indazole compounds and their uses |
摘要 |
The present application relates to therapeutic organic compounds, compositions comprising an effective amount of a therapeutic organic compound; and methods for treating and preventing disease comprising administering and effective amount of a therapeutic organic compound to a subject in need thereof. |
申请公布号 |
US8987275(B2) |
申请公布日期 |
2015.03.24 |
申请号 |
US201113583974 |
申请日期 |
2011.02.18 |
申请人 |
Dana-Farber Cancer Institute, Inc. |
发明人 |
Gray Nathanael;Zhou Wenjun;Deng Xianming |
分类号 |
A61K31/497;A01N43/54;A61K31/506;A01N43/56;A61K31/415;C07D231/56;A61K31/496;C07D401/10;C07D403/12;A61K31/4184;A61K45/06 |
主分类号 |
A61K31/497 |
代理机构 |
Brinks Gilson & Lione |
代理人 |
Brinks Gilson & Lione |
主权项 |
1. A compound of the Formula I: or a pharmaceutically acceptable salt thereof, wherein: X is a bond; R1a is selected from methyl, C(O)cyclopropyl, and C(O)-phenyl;
wherein the C(O)-phenyl can be substituted with -piperazinyl-CH3; R1b is H; RA is selected from H, methyl, and QR5, provided that one instance of RA is QR5;
wherein QR5 is selected from —C(O)—C1-6 alkyloxy, —C(O)N(H)—C1-6 alkyl, —C(O)N(H)-phenyl, —NHC(O)—C3-6 cycloalkyl, —NHC(O)-phenyl, and —N(H)C(O)N(H)-phenyl; wherein the phenyl ring is optionally substituted with one to two substituents wherein the substituents are selected from one each of CF3, —CH2-piperazinyl-C1-6alkyl, and -imidazolyl-C1-6alkyl; and n is 1 or 2. |
地址 |
Boston MA US |